These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 33041137)

  • 41. Direct oral anticoagulants as alternative treatment options for the effective long-term treatment of patients with pulmonary embolism in primary care: a review.
    Toth PP
    Ann Med; 2014 Sep; 46(6):341-52. PubMed ID: 24888386
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of Low-Risk Patients with Acute Symptomatic Pulmonary Embolism for Outpatient Therapy.
    Maestre A; Trujillo-Santos J; Riera-Mestre A; Jiménez D; Di Micco P; Bascuñana J; Vela JR; Peris L; Malfante PC; Monreal M;
    Ann Am Thorac Soc; 2015 Aug; 12(8):1122-9. PubMed ID: 26114586
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multicenter Trial of Rivaroxaban for Early Discharge of Pulmonary Embolism From the Emergency Department (MERCURY PE): Rationale and Design.
    Singer AJ; Xiang J; Kabrhel C; Merli GJ; Pollack C; Tapson VF; Wildgoose P; Peacock WF
    Acad Emerg Med; 2016 Nov; 23(11):1280-1286. PubMed ID: 27537530
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hospitalizations and Other Health Care Resource Utilization Among Patients with Deep Vein Thrombosis Treated with Rivaroxaban Versus Low-molecular-weight Heparin and Warfarin in the Outpatient Setting.
    Deitelzweig S; Laliberté F; Crivera C; Germain G; Bookhart BK; Olson WH; Schein J; Lefebvre P
    Clin Ther; 2016 Aug; 38(8):1803-1816.e3. PubMed ID: 27491278
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of pulmonary embolism with rivaroxaban: outcomes by simplified Pulmonary Embolism Severity Index score from a post hoc analysis of the EINSTEIN PE study.
    Fermann GJ; Erkens PM; Prins MH; Wells PS; Pap ÁF; Lensing AW
    Acad Emerg Med; 2015 Mar; 22(3):299-307. PubMed ID: 25716463
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transforming and simplifying the treatment of pulmonary embolism: "safe dose" thrombolysis plus new oral anticoagulants.
    Sharifi M; Vajo Z; Freeman W; Bay C; Sharifi M; Schwartz F
    Lung; 2015 Jun; 193(3):369-74. PubMed ID: 25749665
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Incremental health care resource utilization and economic burden of venous thromboembolism recurrence from a U.S. payer perspective.
    Lin J; Lingohr-Smith M; Kwong WJ
    J Manag Care Pharm; 2014 Feb; 20(2):174-86. PubMed ID: 24456319
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Review of Medical Therapies for the Management of Pulmonary Embolism.
    Panahi L; Udeani G; Horseman M; Weston J; Samuel N; Joseph M; Mora A; Bazan D
    Medicina (Kaunas); 2021 Jan; 57(2):. PubMed ID: 33530544
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Outpatient treatment of pulmonary embolism with dalteparin.
    Kovacs MJ; Anderson D; Morrow B; Gray L; Touchie D; Wells PS
    Thromb Haemost; 2000 Feb; 83(2):209-11. PubMed ID: 10739374
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence and economic burden of pulmonary embolism in Germany.
    Kröger K; Küpper-Nybelen J; Moerchel C; Moysidis T; Kienitz C; Schubert I
    Vasc Med; 2012 Oct; 17(5):303-9. PubMed ID: 22751745
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Utilization and Safety of a Pulmonary Embolism Treatment Protocol in an Emergency Department Observation Unit.
    Stewart M; Bledsoe J; Madsen T; Sturges Z; McGuire T; Rayner T; Hamilton D; Barton E
    Crit Pathw Cardiol; 2015 Sep; 14(3):87-9. PubMed ID: 26214810
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recent developments in the diagnosis and treatment of pulmonary embolism.
    van der Hulle T; Dronkers CE; Klok FA; Huisman MV
    J Intern Med; 2016 Jan; 279(1):16-29. PubMed ID: 26286356
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The YEARS algorithm for suspected pulmonary embolism: shorter visit time and reduced costs at the emergency department.
    van der Pol LM; Dronkers CEA; van der Hulle T; den Exter PL; Tromeur C; Heringhaus C; Mairuhu ATA; Huisman MV; van den Hout WB; Klok FA
    J Thromb Haemost; 2018 Apr; 16(4):725-733. PubMed ID: 29431911
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Outpatient Treatment of Low-risk Pulmonary Embolism in the Era of Direct Oral Anticoagulants: A Systematic Review.
    Maughan BC; Frueh L; McDonagh MS; Casciere B; Kline JA
    Acad Emerg Med; 2021 Feb; 28(2):226-239. PubMed ID: 32779290
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The clinical course of pulmonary embolism patients anticoagulated for 1 year: results of a prospective, observational, cohort study.
    Palla A; Ribas C; Rossi G; Pepe P; Marconi L; Prandoni P
    J Thromb Haemost; 2010 Jan; 8(1):68-74. PubMed ID: 19817998
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reducing the hospital burden associated with the treatment of pulmonary embolism.
    Peacock WF; Singer AJ
    J Thromb Haemost; 2019 May; 17(5):720-736. PubMed ID: 30851227
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Timing of discharge follow-up for acute pulmonary embolism: retrospective cohort study.
    Vinson DR; Ballard DW; Huang J; Rauchwerger AS; Reed ME; Mark DG;
    West J Emerg Med; 2015 Jan; 16(1):55-61. PubMed ID: 25671009
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inpatient resource use and cost burden of deep vein thrombosis and pulmonary embolism in the United States.
    LaMori JC; Shoheiber O; Mody SH; Bookhart BK
    Clin Ther; 2015 Jan; 37(1):62-70. PubMed ID: 25524389
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of venous thromboembolism: adherence to guidelines and impact of physician knowledge, attitudes, and beliefs.
    Caprini JA; Tapson VF; Hyers TM; Waldo AL; Wittkowsky AK; Friedman R; Colgan KJ; Shillington AC;
    J Vasc Surg; 2005 Oct; 42(4):726-33. PubMed ID: 16242561
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pulmonary Embolism Inpatients Treated With Rivaroxaban Had Shorter Hospital Stays and Lower Costs Compared With Warfarin.
    Margolis JM; Deitelzweig S; Kline J; Tran O; Smith DM; Crivera C; Bookhart B; Schein J
    Clin Ther; 2016 Nov; 38(11):2496-2503. PubMed ID: 27751675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.